Overview

Collagen Cross-Linking for Keratoconus/Ectasia With and Without Intacs

Status:
Unknown status
Trial end date:
2021-06-30
Target enrollment:
0
Participant gender:
All
Summary
This study will determine the efficacy of collagen cross linking for progressive keratoconus and ectasia after lasik. It will try and determine which is a more effective treatment: collagen cross linking alone or collagen cross linking combined with Intacs, a treatment which has already been proven to be effective in decreasing corneal curvature in patients with keratoconus.
Phase:
Phase 2/Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Yaron S. Rabinowitz M.D.
Treatments:
Riboflavin
Criteria
Inclusion Criteria:

- progressive keratoconus or ectasia

Exclusion Criteria:

- cornea thinner than 400um

- K readings greater than 60D

- Central corneal scarring